Title
Bayesian Model Averaging for Ligand Discovery.
Abstract
High-throughput screening (HTS) is now a standard approach used in the pharmaceutical industry to identify potential drug-like lead molecules. The analysis linking biological data with molecular properties is a major goal in both academic and pharmaceutical research. This paper presents a Bayesian analysis of high-dimensional descriptor data using Markov chain Monte Carlo (MCMC) simulations for learning classification trees as a novel method for pharmacophore and ligand discovery. We use experimentally determined binding affinity data with the protein pyruvate kinase to train and assess our model averaging algorithm and then apply it to a large database of over 3.7 million molecules. We compare the results of a number of variations on the central Bayesian theme to that of two Neural Network (NN) architectures and that of Support Vector Machines (SVM). The main Bayesian algorithm, in addition to achieving high specificity and sensitivity, also lends itself naturally to classifying test sets with missing data and providing a ranking for the classified compounds. The approach has been used to select and rank potential biologically active compounds and could provide a powerful tool in compound testing.
Year
DOI
Venue
2009
10.1021/ci900046u
JOURNAL OF CHEMICAL INFORMATION AND MODELING
Keywords
Field
DocType
biological data,neural network,bayesian analysis,binding affinity,biological activity,classification tree,markov chain monte carlo,high throughput screening,missing data,support vector machine
Pharmacophore,Data mining,Biological data,Bayesian inference,Markov chain Monte Carlo,Chemistry,Artificial intelligence,Artificial neural network,Variable-order Bayesian network,Support vector machine,Bioinformatics,Machine learning,Bayesian probability
Journal
Volume
Issue
ISSN
49
6
1549-9596
Citations 
PageRank 
References 
2
0.41
4
Authors
3
Name
Order
Citations
PageRank
Nicos Angelopoulos15311.48
Andreas Hadjiprocopis292.01
Malcolm D. Walkinshaw3413.13